Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<a href="https://www.smartkarma.com/entities/28013" target="_blank" data-smartkarma-citation="entities:28013:1">Pnb Metlife (PNBM IN)</a> plans to raise around US$350m in its IPO via a secondary sale. All the owners plan to sell a part of their stake in the IPO. The deal will likely be launched in 2H19.
While operations have been on the right track in terms of growth and product mix, the company still lags its larger peers on most key parameters. Thus, despite its large distribution network the company has failed to gain market share over the past few years.
In this insight, I'll do a quick comparison of PNB Metlife versus its listed peers. You can find my prior IPO coverage for the sector at these links:
<ul>
<li><a href="https://www.smartkarma.com/insights/icici-pru-life-ipo-review-cheaper-than-hdfc-max-life-but-still-might-be-only-fairly-valued" target="_blank">ICICI Pru Life IPO Review - Cheaper than HDFC-Max Life but Still Might Be Only Fairly Valued</a></li>
<li><a href="https://www.smartkarma.com/insights/sbi-life-ipo-faster-better-and-soon-to-be-bigger-but-expensive-nonetheless" target="_blank">SBI Life IPO - Faster, Better and Soon to Be Bigger but Expensive Nonetheless</a></li>
<li><a href="https://www.smartkarma.com/insights/hdfc-standard-life-ipo-great-brand-prudent-product-mix-but-not-such-a-great-price" target="_blank">HDFC Standard Life IPO - Great Brand, Prudent Product Mix but Not Such a Great Price</a></li>
</ul>

Pnb Metlife (PNBM IN) plans to raise around US$350m in its IPO via a secondary sale. All the owners plan to sell a part of their stake in the IPO. The deal will likely be launched in 2H19.
While operations have been on the right track in terms of growth and product mix, the company still lags its larger peers on most key parameters. Thus, despite its large distribution network the company has failed to gain market share over the past few years.
In this insight, I'll do a quick comparison of PNB Metlife versus its listed peers. You can find my prior IPO coverage for the sector at these links:

ICICI Pru Life IPO Review - Cheaper than HDFC-Max Life but Still Might Be Only Fairly Valued
SBI Life IPO - Faster, Better and Soon to Be Bigger but Expensive Nonetheless
HDFC Standard Life IPO - Great Brand, Prudent Product Mix but Not Such a Great Price


PNB Metlife Pre-IPO Quick Take - Doesn't Stack up Well Versus Its Larger Peers

India

PNB MetLife India Insurance Company Limited provides insurance products and services. The Company offers life, protection, and retirement insurance products, as well as wealth, child, rural, investment, and savings plans. PNB MetLife India Insurance serves customers in India.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

PNB MetLife (PNBM IN)

PNB Metlife Pre-IPO Quick Take - Doesn't Stack up Well Versus Its Larger Peers

Pnb Metlife (PNBM IN) plans to raise around US$350m in its IPO via a secondary sale. All the owners plan to sell a part of their stake in the IPO....

Sumeet Singh

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)